CTNNB1 and hepatobiliary neoplasm: With respect to liver cancer, experimental evidence indicates that n-3 LCPUFA could inhibit the growth of hepatobiliary tumor cells, partially through blocking beta-catenin and cyclooxygenase-2 signaling pathways (26, 27).